The Abbott FreeStyle Libre 2 can be used as a real-time continuous glucose monitor (CGM) with an upgrade to the FreeStyle LibreLink app. Please note, the below information comes with a critical update ...

Abbott, a global healthcare leader, announced that the US Food and Drug Administration (FDA) has cleared the FreeStyle Libre 2 iOS application for use with compatible iPhones, providing a ...

Hyderabad: Abbott, the global healthcare leader, announced the launch of its digital health tool, FreeStyle LibreLink app in India. The mobile application will allow people who use the FreeStyle Libre ...

Diabetes patients in the US will have greater flexibility in managing insulin delivery after Insulet announced its Omnipod pump is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous ...

The FDA granted clearance for a standalone reader to be used for glucose management with the FreeStyle Libre 3 CGM. Users will have the option to use either the reader or the device’s smartphone app.

ABBOTT PARK, Ill. and NEW YORK, Sept. 19, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) and WW International, Inc. (WW) (NASDAQ: WW), known as WeightWatchers, announced today the availability of a connected ...

Abbott, the global healthcare company, today announced the launch of the FreeStyle Libre 2 Plus sensor, Abbott’s latest addition to the FreeStyle Libre sensor portfolio. This innovative device offers ...

Diabetics across the UK have been unable to monitor their glucose levels after an update on a popular app caused it to stop working on some phones. The FreeStyle Libre app works by monitoring blood ...